Skip to main content

Avatar Therapy-Linked Emotions Identified in Treatment-Resistant Schizophrenia

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

FRIDAY, June 16, 2023 -- The predominant emotions expressed by patients with treatment-resistant schizophrenia undergoing virtual reality-based Avatar therapy (AT) are mostly neutral, joy, and anger emotions, according to a study published online June 12 in BMC Psychiatry.

Alexandre Hudon, M.D., from the Centre de recherche de l'Institut Universitaire en Santé Mentale de Montréal, and colleagues used content analysis of immersive sessions transcripts and audio recordings for 16 patients with treatment-resistant schizophrenia who underwent AT between 2017 and 2022 to identify the underlying emotions at the core of the patient-Avatar interaction during AT.

The researchers identified anger, contempt/disgust, fear, sadness, shame/embarrassment, interest, surprise, joy, and neutral emotions in the study. Patients mostly expressed neutral, joy, and anger emotions, while interest, disgust/contempt, and neutral emotions were the predominant emotions expressed by the Avatar.

"This study portrays a first qualitative insight on the emotions that are expressed in AT and serves as a steppingstone for further investigation in the role of emotions in the therapeutic outcomes of AT," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted June 2023

Read this next

First Responders With More Debris Exposure Have Higher Risk of Early Dementia

FRIDAY, June 14, 2024 -- More severe exposure to dust or debris among World Trade Center (WTC) responders is significantly associated with a higher risk of dementia at <65...

1990 to 2019 Saw Increase in Life Expectancy in Seniors With T1DM

FRIDAY, June 14, 2024 -- From 1990 to 2019, there was an increase in life expectancy in older people with type 1 diabetes mellitus (T1DM), according to a study published online...

Second Tumors Are Rare After Chimeric Antigen Receptor T-Cell Therapy

FRIDAY, June 14, 2024 -- Second tumors are rarely seen after chimeric antigen receptor (CAR) T-cell therapy, according to a study published in the June 13 issue of the New England...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.